Screener
Amylyx Pharmaceuticals, Inc. AMLX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s EBITDA margin?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported EBITDA margin of -47,186.8% in Q2 2025.
- How has Amylyx Pharmaceuticals, Inc.'s EBITDA margin changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s EBITDA margin decreased by 79711.7% year-over-year, from -59.1% to -47,186.8%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude